Nothing Special   »   [go: up one dir, main page]

Lu et al., 1991 - Google Patents

Temperature dependence of plasmin-induced activation or inhibition of human platelets

Lu et al., 1991

View HTML
Document ID
2168364456428204826
Author
Lu H
Soria C
Cramer E
Soria J
Maclouf J
Perrot J
Li H
Commin P
Schumann F
Regnier O
Publication year

External Links

Snippet

It is known that at 37 degrees C plasmin may have two opposite effects on platelets: at high concentrations (greater than 1.5 caseinolytic units [CU]/mL), plasmin activates platelets; at lower concentrations (0.1 to 1.0 CU/mL) it inhibits platelet activation induced by thrombin …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Similar Documents

Publication Publication Date Title
Lu et al. Temperature dependence of plasmin-induced activation or inhibition of human platelets
Colucci et al. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
Fay et al. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and-independent mechanisms
Broze Binding of human factor VII and VIIa to monocytes.
Braaten et al. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus
Loscalzo et al. Tissue plasminogen activator promotes platelet disaggregation in plasma.
Walsh et al. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI
Adelman et al. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions
Whyte et al. Platelet-mediated modulation of fibrinolysis
Evangelista et al. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases
Bryant Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens
Bilezikian et al. Unique pattern of fibrinogen cleavage by human leukocyte proteases
Rodgers et al. Characterization of the effects of cultured vascular cells on the activation of blood coagulation
CA2060507C (en) Factor xa based anticoagulant compositions
Gurewich et al. Pro‐urokinase and prekallikrein are both associated with platelets: implications for the intrinsic pathway of fibrinolysis and for therapeutic thrombolysis
Schmaier et al. Crotalocytin: characterization of the timber rattlesnake platelet activating protein
Orevi et al. A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis
Budzynski et al. Fibrinogenolytic afibrinogenemia after envenomation by western diamondback rattlesnake (Crotalus atrox)
Taylor Jr et al. Whole blood clot lysis: in vitro modulation by activated protein C
Dubber et al. In vitro and in vivo studies with Trasylol, an anticoagulant and a fibrinolytic inhibitor
Saba et al. Anti-heparin activity of lysosomal cationic proteins from polymorphonuclear leukocytes
Khan et al. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass
Damus et al. A purified procoagulant enzyme from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus): In vivo and in vitro studies
Horowitz et al. Activation of platelet factor 3 by adenosine 5’diphosphate
Lo et al. Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium.